About Us - For a New Culture of Consciousness

Monnica T. Williams, Ph.D. is a board-certified licensed clinical psychologist and Professor in the School of Psychology at the University of Ottawa, where she holds the Canada Research Chair in Mental Health Innovation and Equity. She is also Clinical Director of the Behavioral Wellness Clinics in Connecticut and Ottawa, providing supervision and training in empirically supported treatments.
Her research focuses on BIPOC mental health, culture, and psychopathology, and she has published more than 200 scientific articles on these topics. Current projects include the treatment of racial trauma, improving cultural competence in mental health care, and addressing structural racism. She has held leadership and editorial roles in major professional associations and journals, is a member of the Scientific Advisory Board of the International OCD Foundation, and her work has been featured in leading US and Canadian media outlets.

Dr Anne Katrin Schlag is a Chartered Psychologist and Head of Research at Drug Science. She completed her PhD in Psychology at the London School of Economics and Political Science, before working as Lecturer at King’s College London where she developed her expertise across the spectrum of science and policy making, risk perception, risk management and risk communication. She holds Honorary Fellowships at both Imperial College London and King’s College London. Within her role at Drug Science, she leads the research for the Medical Cannabis Working Group, focusing on controversies surrounding medical cannabis, the improvement of patient access, and the continued development of education and stakeholder communication about medical cannabis. Dr Schlag is currently working on progressing the scientific evidence base of medical cannabis to include Patient-Reported Outcomes, observational studies (such as T21) and the application of Multi-Criteria Decision Analysis to assess the benefits and safety of medical cannabis.

Dr. Ingmar Gorman is a licensed psychologist specializing in helping individuals navigate anxiety, depression, trauma, substance use, and psychedelic experiences. With a deep understanding of the challenges faced by highly geographically mobile individuals and business leaders—gained through both personal and professional experience—Dr. Gorman offers tailored support to clients managing complex lives and transitions.

In addition to his expertise in traditional psychotherapy, Dr. Gorman is a recognized leader in the field of psychedelic therapy. As a cofounder of Fluence, a leading psychedelic education company, he has dedicated his career to training mental health providers and sharing his knowledge with clients and trainees alike.

Dr. Gorman brings firsthand experience from his role as site co-principal investigator on an FDA-approved Phase 3 clinical trial of MDMA-Assisted Psychotherapy for Post-Traumatic Stress Disorder. And as a study therapist in the same trial and in another groundbreaking clinical study of psilocybin for treatment-resistant depression. His clinical work is informed by his extensive research and publication record, which includes topics such as classic psychedelics, ketamine, MDMA, and Psychedelic Harm Reduction and Integration.

Trained in New York City, Dr. Gorman completed his clinical training at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He further honed his expertise during an NIH postdoctoral fellowship at New York University.

Prof. Dr. Maja T. Izquierdo is a university professor, transdisciplinary researcher, and author working at the intersection of Indigenous knowledge systems, psychedelics, transpersonal psychology, neuroarchitecture, and Amazonian cultural heritage. Born in Belgrade and raised between the Amazon and the Balkans, she integrates ancestral knowledge with contemporary scientific and therapeutic approaches.
Prof. Dr. Maja T. Izquierdo is a university professor, transdisciplinary researcher, and author working at the intersection of Indigenous knowledge systems, psychedelics, transpersonal psychology, neuroarchitecture, and Amazonian cultural heritage. Born in Belgrade and raised between the Amazon and the Balkans, she integrates ancestral knowledge with contemporary scientific and therapeutic approaches.
As a psychologist and transpersonal psychotherapist, she researches expanded states of consciousness and the therapeutic implications of Amazonian ceremonial traditions. Through her work in neuroarchitecture, she investigates how ceremonial spatial principles inform contemporary therapeutic environments and healing design.
She regularly lectures internationally and contributes to research and public debates on psychedelics, Indigenous epistemologies, healing, and ecological consciousness.

Dr. Dominique Morisano is a clinical psychologist working with children, adolescents, and adults, licensed in Ontario, New York, Connecticut, Oregon, and Alberta. She completed her training at Duke, Brown, and McGill Universities, followed by a postdoctoral fellowship in schizophrenia, adult clinical psychology, and addiction psychiatry at the University of Toronto and CAMH. She has held academic and clinical roles at institutions including Columbia University–affiliated Child and Family Institute in New York, the University of Toronto (OISE), Erasmus University in the Netherlands, and several mental health organisations in Canada and the US. Her work focuses on goals and motivation, mental health and addiction services, implementation of best practices, and psychedelic-assisted therapies. She has run a private psychology practice since 2011 and works as an independent consultant, trainer, and supervisor in psychedelic science and therapy for organisations such as Fluence Training, Journey Clinical, Beckley Retreats, Naropa University, and Mind Foundation. She is co-founder and Chair of the Board of the nonprofit Psychedelics R2R and holds visiting and adjunct academic appointments at Erasmus University Rotterdam, CAMH, the University of Toronto, and the University of Ottawa.

Giorgio Samorini is an Italian ethnobotanist and ethnomycologist who has spent more than three decades researching the traditional, historical, and archaeological use of psychoactive plants and fungi. An independent scholar, he has carried out fieldwork with communities in Africa, Latin America, Asia, and Europe and is editor-in-chief of Eleusis: Journal of Psychoactive Plants & Compounds, one of the pioneering journals in this field. He is the author of Animals and Psychedelics: The Natural World and the Instinct to Alter Consciousness and numerous books and articles on psychoactive mushrooms, ancient cults, and rock-art depictions of inebriating plants, including a widely cited overview of the earliest archaeological evidence for human–psychedelic relationships and a recent multi-part study of iboga and Bwiti cults in Equatorial Africa. As a member of the Scientific Advisory Board of the Psychedelia-Stiftung (Psychedelia Foundation), he contributes deep expertise on ethnobotany, cultural history, and cross-cultural use of psychoactive plants, helping to ground the foundation’s research and education in robust anthropological and historical evidence.

Adriana D’Arienzo is a medical doctor specialized in Anesthesiology and Intensive Care. She worked as a consultant anesthesiologist and intensivist in cardiothoracic anesthesia and transplantation units at the Medical University of Vienna. Alongside her clinical activity, she developed a focused interest in neuropharmacology and the neuroscience of psychedelic substances, contributing to several peer-reviewed scientific publications. In 2021, she co-authored with Giorgio Samorini the Italian two-volume scholarly work “Terapie Psichedeliche”. Since relocating to Mallorca in 2019, she has been working at Son Llàtzer University Hospital in Palma de Mallorca within the Department of Anesthesiology and Pain Medicine, where she specializes in chronic pain management and advanced neuromodulation.